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Background: A significant proportion of premature infants present with respiratory failure early in life and require
supplemental oxygen and some form of mechanical respiratory support.
Findings: Many technical advances in the devices for neonatal respiratory support have occurred in recent years
and new management strategies have been developed and evaluated in this population. This article describes
some of these novel methods and discusses their application and possible advantages and limitations.
Conclusion: Newer methods of respiratory support have led to marked improvement in outcome of premature
infants with respiratory failure. Some of these strategies are very promising but further investigation to evaluate
their short term efficacy and impact on long term respiratory and other relevant outcomes is needed before wider
use.
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Different modes of respiratory support and oxygen sup-
plementation are commonly used in premature infants
in respiratory failure. The strategies of respiratory sup-
port and the devices utilized for this purpose have
evolved considerably. Since the earlier studies describing
the use of intermittent positive pressure ventilation, the
advantages of continuous distending pressure in the
form of nasal CPAP, the use of the T piece to provide a
continuous flow of gas from which the patient can
breathe spontaneously and the application of positive
end-expiratory pressure [1-10] have constituted the basis
of the modern neonatal respiratory support. These, com-
bined with the introduction of therapies such as ante-
natal steroids and exogenous surfactant, have produced
improvements in survival of high risk premature infants
in respiratory failure.
The respiratory outcome of these high risk infants
has also improved considerably compared to the severe
lung injury induced by high positive pressure and ele-
vated inspired oxygen observed during the early years
of respiratory support in premature infants [11-13]. These
improvements resulted from a better understanding of the* Correspondence: ebancalari@med.miami.edu
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article, unless otherwise stated.damage associated with the aggressive use of mechanical
ventilation and high inspired oxygen levels to maintain
normal arterial blood gases and achieve control of the in-
fant’s ventilation [14-16]. Current strategies of neonatal re-
spiratory support aim to produce adequate gas exchange
while minimizing the risk of lung injury and by facilitating
weaning with ventilator strategies that primarily assist the
infant’s spontaneous respiratory effort. More recent ad-
vances seek to adjust the different forms of respiratory
support to the infant’s changing needs and further facili-
tate their spontaneous breathing and minimize the risk of
lung injury. These include advances in monitoring tech-
nology and automation of specific parameters of the re-
spiratory support.Review
Synchronized mechanical ventilation
The use of the T piece and the circulating bias flow in
neonatal mechanical ventilators to maintain PEEP and
provide cycles where the pressure increases to the set
peak inspiratory pressure (PIP) level at fixed intervals
became known as time-cycled pressure-limited (TCPL)
ventilation. The intermittent tidal inflation during
TCPL is also known as intermittent mandatory ventila-
tion (IMV).Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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quency depending on the level of ventilatory support re-
quired by the infant. The cycling frequency is gradually
reduced as the infant contribution to minute ventilation
increases. During this process there is continuous inter-
action between the infant’s spontaneous breathing and
the ventilator positive pressure cycles. At times, ventila-
tor cycles can interfere with the infant’s breathing when
they occur late in the infant’s spontaneous inspiration or
during exhalation.
The use of various sensors in neonatal ventilators to
detect the infant’s spontaneous inspiration can achieve
synchronized delivery of the positive pressure cycles
with the onset of the infant’s inspiration. This resulted in
the development of various modalities of support includ-
ing synchronized IMV (SIMV), assist/control (A/C) and
pressure support ventilation (PSV) [17-22]. The tracing
in Figure 1 shows representative recordings from a pre-
mature infant undergoing SIMV.
Findings
Clinical studies have shown that the addition of the
pressure generated by the infant’s respiratory pump and
that produced by the ventilator during synchronized
ventilation result in a more consistent tidal volume and
improved ventilation compared to IMV, leading to a
more stable and effective gas exchange [23-29]. Clinical
trials have consistently shown faster weaning and shorterFigure 1 Synchronized intermittent mandatory ventilation. Tracings of flow
volume (VT) obtained from a premature infant undergoing SIMV. The interv
synchrony with the infant’s inspiratory efforts (negative deflections in the e
infant’s spontaneous inspiratory effort achieve a larger tidal volume than thduration of mechanical ventilation with synchronized
modes compared to IMV which is more evident among
the more premature infants [30-35]. These studies
underline the importance of preserving the infant’s spon-
taneous breathing and provide only the necessary level
of support to assist ventilation better than controlling
the infant’s ventilation and gas exchange.
In spite of the reduction in duration of mechanical
ventilation the effects on respiratory outcome, namely
bronchopulmonary dysplasia (BPD), have not been con-
sistent. These however appear to be more striking in
those studies enrolling more immature infants at higher
risk of BPD [36]. As described, the reduction in BPD by
synchronized ventilation is greatest in those studies
where the study population had a higher rate of BPD.
Studies have not shown clear advantages of one syn-
chronized modality versus others except for a slightly
faster weaning with A/C [37,38]. The similarity of the ef-
fect is likely due to the fact that these modalities provide
comparable levels of support during the initial phase of
acute respiratory distress where higher rates used in
SIMV provide similar support as A/C or PSV. One study
showed the additional use of PSV to SIMV can facilitate
the weaning compared to SIMV alone. Lower peak pres-
sure levels with PSV boosted the spontaneous breaths
reducing the reliance on larger SIMV breaths [39]. Figure 2
shows a representative recording from an infant receiving
SIMV combined with pressure support., esophageal pressure (PEsoph), ventilator pressure (PVent) and tidal
al between SIMV cycles is adjusted by the ventilator to maintain
sophageal pressure). The combination of the positive pressure and the
at of the non-assisted spontaneous breaths.
Figure 2 Synchronized intermittent mandatory ventilation combined with pressure support. Tracings of flow, tidal volume (VT) and ventilator
pressure (PVent) obtained from a premature infant switched from SIMV to SIMV combined with pressure support. The tidal volume from
spontaneous breaths assisted by pressure support is larger than the tidal volume from non-assisted spontaneous breaths between SIMV cycles.
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rendered ineffective if the breath sensing parameters are
not set properly to detect the infant’s spontaneous in-
spiration. When this occurs the infant receives only
mandatory breaths and can experience the consequent
asynchrony. The most important concern with synchro-
nized modalities is the risk of autocycling when artefacts
or a too sensitive threshold for synchrony can result in
the ventilator providing a cycle that is not necessarily
triggered by a spontaneous inspiration. This is a greater
concern in modes such as A/C and PSV when there is a
risk of hypocapnia or gas trapping because of autocy-
cling at very high ventilator rates [40].
Monitoring during mechanical ventilation
For many years the adequacy of ventilation was limited
to monitoring of blood gases, radiographic evaluation,
visual assessment of chest expansion and monitoring of
breathing frequency by transthoracic impedance. The
introduction of flow sensors for synchronization also
provided the clinician with the ability to monitor the ad-
equacy of tidal and minute volume. This led to a more
objective evaluation of the tidal inflation and to a better
titration of PIP which may be associated with reduced
lung injury [41-43].
Non-invasive respiratory support
In recent years non-invasive respiratory support by nasal
continuous positive airway pressure (NCPAP) and nasal
intermittent positive pressure ventilation (NIPPV) have
being increasingly used in the premature infant instead
of mechanical ventilation. The effects of the applicationof a continuous distending pressure with NCPAP in-
clude stabilization of lung volume and airway patency
leading to improved oxygenation and reduced apnea.
NIPPV may enhance the effects of NCPAP by increasing
ventilation and mean airway pressure, by washing out of
CO2 from the upper airway and by a possible enhance-
ment of the respiratory drive.Findings
Clinical studies in preterm infants after extubation to
NIPPV showed increased ventilation and reduced PaCO2
and breathing effort [44,45]. In more stable infants NIPPV
did not increase ventilation or improve gas exchange but
it reduced breathing effort compared to NCPAP [46-48].
This suggests a greater benefit of NIPPV over NCPAP in
infants with some degree of ventilatory failure or those
struggling to maintain adequate ventilation. Although
NIPPV has not been consistently shown to be more effect-
ive than N-CPAP in reducing apnea, its efficacy appears to
increase when synchronized to the infant’s spontaneous
breathing [44,49-52].
Randomized controlled trials in premature infants with
RDS have shown that NIPPV can reduce the need for
mechanical ventilation compared to NCPAP [53-58]. The
efficacy of synchronized NIPPV in reducing extubation
failure compared to NCPAP has been shown consistently
in randomized trials [59-63]. Although NIPPV is more ef-
fective than NCPAP in reducing the need for mechanical
ventilation, studies have not demonstrated a significant
impact of NIPPV compared to NCPAP on pulmonary out-
come [53-64]. These clinical trials did not show increased
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tension or pulmonary air leaks.
Although the use of both NCPAP and NIPPV has be-
come very common, there is considerable need to fur-
ther develop and test newer technologies to improve
patient interfaces, synchronization of the ventilator with
the patient and to improve transmission of the positive
pressure to the infant’s airways.Automation of respiratory support
The peak pressure during each ventilator cycle set by the
clinician provides a constant level of ventilatory support.
However, the ventilatory needs of the premature infant
in respiratory failure can vary considerably within short
periods of time. These fluctuations in respiratory me-
chanics and spontaneous breathing effort can lead to sig-
nificant variations in ventilation. Because the support
level provided by ventilatory modes such as SIMV, IMV,
A/C or PSV provide constant peak pressure and/or
mandatory rate, the set levels generally exceed those re-
quired by premature infants in order to maintain ad-
equate ventilation at all times, even at times when the
infant’s needs may be less. In order to adjust the ventila-
tory support to the infant’s needs, methods for automatic
adjustment of the peak pressure and frequency have
been incorporated to neonatal ventilators.Figure 3 Volume guarantee ventilation. Tracings of flow, tidal volume (VT)
fluctuations in ventilation. The ventilator peak pressure is automatically incr
instability and it declines as ventilation becomes more stable.Volume targeted ventilation
During volume targeted ventilation, the peak pressure is
automatically adjusted to maintain the tidal volume at
the level set by the clinician. In this manner, when re-
spiratory mechanics improve or the infant’s respiratory
pump produces a larger tidal volume the ventilator re-
duces the peak pressure provided in each cycle and vice-
versa. The adjustments in ventilator pressure are expected
to provide better ventilation stability. Figure 3 shows a
representative recording from a premature infant receiv-
ing volume guarantee ventilation.
During volume targeted ventilation the ventilator can
only control the peak positive pressure applied on each
cycle but cannot determine the negative pressure pro-
duced by the infant’s respiratory pump. The targeted
volume in this modality is essentially a minimum tidal
volume level but does not prevent the spontaneous
inspiratory effort from generating breaths that exceed
the target level.
Findings
Clinical studies have shown improved stability and
reduced exposure to excessive or insufficient tidal
volumes and an effective automatic reduction in PIP
[65-67]. Clinical trials have demonstrated volume tar-
geted ventilation modes can facilitate weaning from
mechanical ventilation compared to conventional manualand ventilator pressure (PVent) from a premature with frequent
eased to maintain tidal volume at the target level during periods of
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data from these studies shows a significant reduc-
tion in the rate of the composite outcome BPD or
death [73].
Although volume targeted ventilation appears to be
safe there are important aspects to be considered in
regards to its efficacy. Different ventilators utilize various
methods to achieve volume targeted ventilation. Some of
the ventilators make the automatic adjustments in pres-
sure based on the volume delivered by the ventilator to
the breathing circuit while others take the tidal volume
measured with proximal flow sensors or from an esti-
mate of the tidal volume from measurements obtained
by flow sensors built in the ventilator. Ventilators also
vary on whether the adjustments in pressure are made
based on the tidal volume measured during the inspira-
tory phase or exhaled volume or in the timing of the
pressure adjustment, i.e. instantaneously as the volume
is delivered or from one cycle to the next.
Although there is sufficient evidence to recommend
avoidance of extreme high or low tidal volumes, there is
insufficient information in regards to the optimal tidal vol-
ume to be used in infants of different gestational ages, in-
dications for mechanical ventilation and during the
different phases of respiratory failure. Data are also lacking
on the most adequate tidal volume target when volume
targeted ventilation is provided at different mandatory
rates with SIMV or when it is used to assist every spon-
taneous inspiration in A/C or PSV.
Targeted minute ventilation
The ventilatory support provided during conventional
ventilation at a frequency set by the clinician provides a
relatively constant minimum level of minute ventilation.
This level of support may be adequate for most of the
time but at times it can be insufficient and/or excessive
to meet the infant’s needs. This is because the contribu-
tion of the infant’s spontaneous breathing effort to the
total minute ventilation varies considerably depending
on the consistency of the respiratory pump, stability of
respiratory mechanics and the infant’s respiratory drive.
Targeted minute ventilation consist of automatic ad-
justments of the cycling frequency of the ventilator to
maintain the minute ventilation at a level set by the clin-
ician or alternatively to keep the total respiratory rate at
a preset level. Because the ventilator can only control its
own cycling frequency and not the infant’s, these modal-
ities only target a minimum level of minute ventilation
or respiratory rate.
Findings
In short term clinical studies in preterm infants these
automatic modalities have been shown to be effective in
reducing the ventilator frequency without affecting gasexchange [74,75]. Modalities such as PSV can be used to
assist every spontaneous inspiration and in the event of
apnea the ventilator provides mandatory cycles at a fre-
quency and PIP set by the clinician. The effects of PSV
as a stand- alone mode and the impact of the back-up
ventilation provided during apnea have not been evalu-
ated in preterm infants. Other methods include auto-
matic adjustments to the cycling frequency not only
when ventilation declines but also in response to de-
creases in arterial oxygen saturation [76].
Although these modalities are promising alternatives
to tailor the respiratory support to the changing needs
of the infant, to date there have not been randomized
trials evaluating their efficacy in improving respiratory
outcome in this population.
Newer experimental developments include simultan-
eous adjustments of both the cycling frequency and the
peak pressure of the ventilator. The combined approach
was more effective than conventional pressure ventila-
tion or the individual automatic adjustment of pressure
or frequency in maintaining oxygenation in an animal
model of induced episodic hypoxemia [77].Proportional assist ventilation and neurally adjusted
ventilatory assist
In proportional assist ventilation (PAV) the ventilator as-
sists the infant’s respiratory pump to overcome elastic or
resistive loads due to the underlying lung disease. For
this, the ventilator pressure is automatically adjusted in
proportion to the measured tidal volume, flow or both.
The proportionality factor set by the clinician deter-
mines the degree of unloading or compensation for the
disease induced respiratory loads. When PAV is used the
infant essentially perceives his respiratory mechanics
have improved because of the simultaneous provision of
positive pressure as the infant generates each inspiratory
effort.Findings
In clinical studies PAV has been shown to be effective in
reducing the inspiratory effort and providing ventilation
with lower ventilator pressures compared to conven-
tional modes in premature infants recovering from re-
spiratory failure or with evolving chronic lung disease
[78,79].
Neurally adjusted ventilatory assist (NAVA) is a modality
where the ventilator pressure is automatically adjusted
in proportion to the measured electrical activity of the
diaphragm. NAVA is intended to enhance the infant’s
ability to generate VT and/or reduce the diaphragm’s
activity. Figure 4 shows a representative recording from
a premature infant undergoing NAVA.
Figure 4 Neurally adjusted ventilatory assist. Tracings of ventilator pressure (PVent), flow, tidal volume (VT) and diaphragmatic electrical activity
(EADiaphragm) from a premature undergoing NAVA. The ventilator pressure is proportional to the magnitude of the electrical activity of the diaphragm
during each inspiration. Note the absence of support during a breathing pause. A longer pause would require a backup rate of ventilator cycles.
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In short term studies NAVA has been shown to maintain
similar or better ventilation and gas exchange with lower
pressures and better synchrony compared to conven-
tional ventilation in preterm infants, but without a sig-
nificant reduction in diaphragmatic activity [80-83].
PAV and NAVA are promising alternatives but their
long term effects need to be explored to determine their
impact on weaning from mechanical ventilation and on
pulmonary outcomes in high risk preterm infants.Automatic control of inspired oxygen
Most preterm infants in respiratory failure or with chronic
lung disease require supplemental oxygen but because of
their prematurity they are at risk of damage to their eyes
and other organs if the arterial oxygen levels are excessive
or insufficient [84,85]. Although arterial oxygen saturation
levels are continuously monitored by pulse oximetry
(SpO2) these infants spend considerable periods of time
outside the intended prescribed range [86,87]. While fluc-
tuations below the targeted range of oxygenation are usu-
ally episodic and due to the infant’s respiratory instability,
high SpO2 levels in oxygen dependent infants are gener-
ally induced by excessive fraction of inspired oxygen
(FiO2) [88-90].Systems for automatic control of FiO2 have been de-
veloped with the goal of improving the maintenance of
SpO2 within a target range and consequently reduce ex-
posure to hyperoxemia and supplemental oxygen as well
as to attenuate episodes of hypoxemia. Figure 5 shows
representative recordings of SpO2 and FiO2 from a pre-
mature infant undergoing automatic control of FiO2.
Findings
In short term clinical studies these systems have been
shown to be more effective than manual adjustments by
the routine staff and by a fully dedicated nurse at bed-
side in keeping SpO2 within the target range [91-104]. In
these studies the reduction in hyperoxemia and oxygen
exposure was also significant particularly in premature
infants with frequent fluctuations in oxygenation. In
these infants the clinical staff often tolerates SpO2 levels
well above the intended range to prevent or attenuate
the episodes of hypoxemia.
Although the systems of automatic control of FiO2
have shown promising results, their impact on longer
term ophthalmologic, respiratory and neurologic out-
come still remains to be determined in large scale clin-
ical trials.
These automated systems are intended to replace the
repetitive task of manual titration of FiO2 and in this
Figure 5 Automatic control of inspired oxygen. Recordings of SpO2 and FiO2 from a premature infant during 2 hours of automatic control of FiO2.
The ventilator automatically increases FiO2 when SpO2 declines below the target in order to keep SpO2 within the target range (horizontal lines). The
magnitude of the increases in FiO2 are proportional to the decline in SpO2. FiO2 is brought back to the baseline level (thicker horizontal line) after SpO
returns to the target range.
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studies mentioned above have shown a striking reduc-
tion in the number of manual FiO2 adjustments by the
clinical staff during automatic FiO2 control. While this is
a positive finding, these systems are not a substitute for
continuous clinical observation of the patient and should
not reduce attentiveness of the caregiver. The ability to
integrate monitoring of SpO2 and the need for FiO2 into
smarter alarms and warnings can mitigate potential situ-
ations when automatic adjustments could mask a re-
spiratory deterioration and may also enhance the care
since FiO2 levels are not commonly monitored at
present time.
These automatic systems aim to maintain a range of
SpO2 set by the clinician. However, at this time there is
no consensus on the most appropriate target range of
SpO2 for premature infants due to the conflicting and
competitive clinical outcomes of different target ranges.
In some trials lower oxygenation target ranges appear to
reduce severe retinopathy of prematurity and BPD butalso appear to reduce survival of the extremely prema-
ture infant [105-107]. It is also important to note that
target ranges of SpO2 in observational and interventional
randomized clinical trials were not closely matched by the
actual SpO2 levels. Therefore caution is recommended
when setting the target range in an automatic system as
this would maintain such range more closely than the
routine care. This may uncover effects of different
target ranges that were not previously observed simply
because the maintenance of SpO2 within such range
was not adequate.
Conclusion
In summary, advances in the devices and new strategies
to provide invasive and non-invasive respiratory support
have achieved considerable improvements in the man-
agement of the critically ill premature infant. Further in-
vestigation to evaluate their short and long term efficacy
and impact on respiratory and other relevant clinical
outcomes is needed.
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